Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Trojano
Pnd10 - Genius Rwe Study (Fingolimod Real World Evidence Italian Multicenter Observational Study in Multiple Sclerosis)preliminary Results
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study
Multiple Sclerosis International
Neurology
The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study
PLoS ONE
Multidisciplinary
Prm82 - Real World Evidence (Rwe) From Italian NHS-Aifa Registries
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Real-World Outcomes in Fingolimod-Treated Patients With Multiple Sclerosis in the Czech Republic: Results From the 12-Month GOLEMS Study
Clinical Drug Investigation
Medicine
Pharmacology
Long-Term Safety and Real-World Effectiveness of Fingolimod in Relapsing Multiple Sclerosis
Patient Related Outcome Measures
5psq-075 Safety Profile of Fingolimod in Real World Clinical Practice: A Preliminary Study
Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting
Journal of Neurology & Neurophysiology
Pnd13 - Real World Evidence (Rwe) on Impact of Age on Long-Term Persistence to Disease Modifying Therapies (Dmts) in Relapsing-Remitting Multiple Sclerosis (Rrms) in Australia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
049 Real World Evidence (RWE) on Impact of Age on Long-Term Persistence to Disease Modifying Therapies (DMTS) in Relapsing-Remitting Multiple Sclerosis (RRMS) in Australia
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
